Technology
Health
Medical

Neuronetics

$9.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-1.58%) As of 3:16 PM EDT today
-$0.16 (-1.58%) Today

Why Robinhood?

You can buy or sell Neuronetics and other stocks, options, ETFs, and crypto commission-free!

About STIM

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. Read More The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Employees
140
Headquarters
Malvern, Pennsylvania
Founded
2003
Market Cap
186.70M
Price-Earnings Ratio
Dividend Yield
Average Volume
57.66K
High Today
$10.14
Low Today
$9.90
Open Price
$10.06
Volume
29.22K
52 Week High
$39.39
52 Week Low
$8.90

Collections

Technology
Health
Medical
Therapy
Advertising and Marketing
Education
Business Services
2018 IPO

STIM Earnings

-$30.60
-$20.50
-$10.39
-$0.29
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.41 per share
Actual
-$0.39 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.